Family screening
Think Fabry, think screening at-risk family members.1
Clinical and genetic screening of family members can decrease time to diagnosis for at-risk family members and ensure earlier and more effective disease-specific management of Fabry disease before progression.1,2
Create a detailed family history following the X-linked inheritance pattern to identify at-risk family members2
Adapted from Laney D and Fernoff P. 2008.2
5 additional family members are newly diagnosed (previously undiagnosed) on average through family screening of one Fabry index patient.2
-
Ortiz A, et al. Mol Genet Metab. 2018;123(4):416-427.
-
Laney D and Fernhoff P. J Genet Counsel. 2008;17:79–83.
Articles liés
Fabry disease
Fabry disease is an X-linked lysosomal storage disease due to a defect in the gene encoding the lysosomal enzyme alpha-galactosidase A (α-Gal A), causing progressive cellular accumulation of the substrate globotriaosylceramide (GL-3) and globo-triaosylsphingosine (lyso-GL-3).
When to treat
Think Fabry, think early treatment to help slow or prevent life-threatening disease progression.1,2
Renal involvement in Fabry disease
Think Fabry, think renal involvement that may present early in life and could go undetected.
Les contenus accessibles par ce site sont destinés exclusivement aux Professionnels de Santé.
Les contenus accessibles par ce site sont destinés
exclusivement aux Professionnels de Santé.
Sanofi met a votre disposition, sur un portail unique dédié aux professionnels de santé, des contenus exclusifs comprenant des contenus scientifiques et des outils pour votre pratique quotidienne.